Gengwen Tian, MD, PhD
Department or Service
- Texas Medical Center
Clinical Fellow, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
|Driscoll Children’s Hospital||residency||Pediatrics||2019|
|Baylor College of Medicine||PhD||Doctor of Philosophy, Immunology||2016|
|Harbin Medical University||medical school||Doctor of Medicine||2011|
Dr. Gengwen Tian started her pediatric hematology/oncology fellowship training in 2019. Dr. Tian has had a strong passion for treating patients with malignancies since medical school. With the goal of understanding more about cancer biology and discovering new treatment, Dr. Tian pursued her PhD research in developing new cell therapies against neuroblastoma and lymphoma at the Center for Cell and Gene Therapy Center at Baylor College of Medicine. Dr. Tian started her pediatric hematology/oncology fellowship in 2019 with the goal of becoming a physician-scientist, specializing in the treatment of childhood cancers.
Dr. Tian finds it very rewarding to treat and interact with pediatric oncology patients. While in residency, Dr. Tian did multiple clinical rotations at both St. Jude Children’s Research Hospital and the National Institutes of Health (NIH). During this time, Dr. Tian gained knowledge in both common pediatrics cancers, as well as rare childhood cancers. Dr. Tian was actively involved in quality improvement projects during residency, such as a central line infection study and resident workshops in improving communication skills with patients and families.
Dr. Tian is interested in treating a variety of childhood malignancies and participating in the development of new therapeutics against childhood cancers. Dr. Tian would like to continue her research on utilizing immune cells to tackle pediatric solid tumors.
Dr. Gengwen Tian is interested in developing new immunotherapies against various childhood cancers. Dr. Tian was involved in multiple research projects, ranging from cancer vaccine development to novel cell therapy against lymphoma and neuroblastoma. Dr. Tian’s work has been published in multiple scientific journals.
Currently, Dr. Tian’s PhD work has progressed to a clinical trial to treat refractory neuroblastoma. Dr. Tian’s goal is to understand how the immune system interacts with cancer cells and how we can train the immune system to better tackle cancer malignancies. Dr. Tian is interested in various tumors, including neuroblatoma, osteosarcoma and Ewing sarcoma.
|American Academy of Pediatrics (AAP)||Member|
|American Society of Clinical Oncology (ASCO)||Member|
|American Society of Hematology (ASH)||Member|
|American Society of Pediatric Hematology/Oncology (ASPHO)||Member|
|Children’s Oncology Group (COG)||Member|